Skip to main content
Figure 2 | Diabetology & Metabolic Syndrome

Figure 2

From: Bezafibrate improves insulin resistance evaluated using the glucose clamp technique in patients with type 2 diabetes mellitus: a small-scale clinical study

Figure 2

Plasma glucose levels and IRI in the MTTs before and after 12 weeks of treatment with bezafibrate. ● = mean values at baseline; ○ = mean values after 12 weeks of treatment with bezafibrate (n = 12). IRI = immunoreactive insulin; MTT = meal tolerance test; PG = plasma glucose. **p < 0.01 vs. baseline (paired t test).

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us